Today: 30 April 2026
SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

New York, Jan 5, 2026, 13:54 EST — Regular session

  • SiTime shares swung sharply, turning from an early gain into a near 9% drop.
  • The timing-chip maker had recently traded above Wall Street’s average price target, a level that can trigger valuation scrutiny.
  • Investors are watching the broader semiconductor tone and SiTime’s next earnings window for direction.

SiTime Corp shares slid about 9% on Monday afternoon, reversing an earlier rise and wiping out a chunk of the timing-chip maker’s start-of-year gains. The Nasdaq-listed stock was down $33.46 at $336.50, after trading as high as $382 and as low as $333.33.

The move matters because SiTime has become a high-beta way to play the semiconductor cycle, and investors are reassessing richly valued niche chip names as 2026 gets underway. A sharp intraday turn like Monday’s often signals fast money leaving crowded positions, even when the broader sector is in favor.

The selloff also puts the spotlight back on valuation versus expectations, with the next major company catalyst still weeks away. Traders will be watching whether the stock can stabilize around widely watched reference points after running ahead of some published targets.

A Nasdaq.com note earlier on Monday flagged that SiTime had climbed above the average analyst 12-month target price of $355, with the stock changing hands around $369.96 per share. The same note said targets in its sample ranged from $260 to $420, underlining how dispersed views remain on where the shares should settle.

SiTime’s drop came as chip stocks broadly extended their early-2026 rally, helped by ongoing enthusiasm around AI-linked spending. The PHLX Semiconductor Index — a benchmark basket of major chip names — was up about 1.7% in midday trading, and D.A. Davidson’s head of technology research Gil Luria told MarketWatch: “Investors realize the great data-center build-out is still not reflected across all of the stocks that are impacted.” Marketwatch

In the wider tape, U.S. indexes were higher, but traders were still digesting a softer-than-expected ISM manufacturing reading and looking ahead to a heavy week of labor-market and services-sector data. A Nasdaq.com market note said the market’s focus includes ADP employment and the ISM services report midweek, and the monthly U.S. payrolls report on Friday.

SiTime sells precision timing devices — components that keep electronic systems synchronized — and it markets its products as MEMS-based, meaning micro-electro-mechanical systems built with semiconductor-style manufacturing rather than traditional quartz crystals. That positioning ties the company to demand in data centers, communications and other electronics that require stable clocks.

After Monday’s reversal, investors are likely to key on whether SiTime can reclaim the mid-$350s area that recently matched the average published price target, and whether it can hold above the day’s low near $333. Elevated turnover versus recent averages could keep the stock sensitive to momentum flows.

But the setup cuts both ways. If interest-rate expectations shift, or if the broader semiconductor trade cools, high-multiple stocks that have run hard can see air pockets as buyers step back and liquidity thins.

Stock Market Today

  • Eli Lilly (LLY) Shares Drop 7.6% in Week, DCF Model Suggests 40% Undervaluation
    April 29, 2026, 11:18 PM EDT. Eli Lilly's (LLY) stock price has dropped 7.6% in the past week, down 21.2% year to date despite a strong 3-year return exceeding 100%. The recent pullback prompts questions on valuation. A Discounted Cash Flow (DCF) analysis, which forecasts future free cash flows discounted to present value, estimates the stock's intrinsic value at $1,427.87, about 40.4% above the current $851.21 share price. This suggests the shares might be undervalued despite their recent decline. Conversely, Eli Lilly's price-to-earnings (P/E) ratio stands at 36.9, representing a premium compared to the pharmaceutical industry average of 15.9 and peers at 19.2, indicating the market prices in higher growth expectations or lower risk. Investors face a mixed picture: a substantial discount on cash flow metrics but a premium relative to earnings multiples.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Bloom Energy stock jumps again: BE extends rally on $600 million Wells Fargo credit line as jobs report looms
Previous Story

Bloom Energy stock jumps again: BE extends rally on $600 million Wells Fargo credit line as jobs report looms

GE Aerospace stock hits fresh high as Wall Street sizes up the next earnings test
Next Story

GE Aerospace stock hits fresh high as Wall Street sizes up the next earnings test

Go toTop